drugset
drugset / Trial / NCT06819488

A Clinical Study of Mass Balance of [14C]HRS-7535

NCT06819488 ↗

Phase 1 Completed 6 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The objective is to evaluate the mass balance of \[14C\]HRS-7535 in healthy adult Chinese subjects.

Timeline

Start
2025-02-27
Primary completion
2025-04-16
Completion
2025-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-7535 Small molecule — —

Indications

type 2 diabetes mellitus